rubrofusarin B has been researched along with oltipraz in 1 studies
| Studies (rubrofusarin B) | Trials (rubrofusarin B) | Recent Studies (post-2010) (rubrofusarin B) | Studies (oltipraz) | Trials (oltipraz) | Recent Studies (post-2010) (oltipraz) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 358 | 28 | 40 |
| Protein | Taxonomy | rubrofusarin B (IC50) | oltipraz (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.415 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Carter, AC; Cichewicz, RH; King, JB; Mattes, AO; Singh, N | 1 |
1 other study(ies) available for rubrofusarin B and oltipraz
| Article | Year |
|---|---|
Natural-Product-Inspired Compounds as Countermeasures against the Liver Carcinogen Aflatoxin B
Topics: Aflatoxin B1; Antineoplastic Agents, Phytogenic; Biological Products; Carcinogens; Hepatocytes; Humans; Liver; Molecular Structure; Protective Agents | 2019 |